Life Tech's Invitrogen Chooses Not to Commercialize HUPO's Protein-Standard Mixture | GenomeWeb

This story originally ran on Oct. 8.

Life Technologies division Invitrogen has decided not to manufacture or sell the protein-standard mixture it developed in collaboration with the Human Proteome Organization.

In the meantime, HUPO is in negotiations with another vendor to commercialize the mixture developed to serve as a benchmark for the mass spectrometry-based proteomics community. Officials declined to identify the vendor.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.